BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24903791)

  • 1. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
    da Silva Antunes R; Pinto M; Trajman A
    Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.
    Van Rie A; Page-Shipp L; Hanrahan CF; Schnippel K; Dansey H; Bassett J; Clouse K; Scott L; Stevens W; Sanne I
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):368-72. PubMed ID: 23407225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Pinto M; Steffen RE; Cobelens F; van den Hof S; Entringer A; Trajman A
    Int J Tuberc Lung Dis; 2016 May; 20(5):611-8. PubMed ID: 27084814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.
    Abdurrahman ST; Mbanaso O; Lawson L; Oladimeji O; Blakiston M; Obasanya J; Dacombe R; Adams ER; Emenyonu N; Sahu S; Creswell J; Cuevas LE
    J Clin Microbiol; 2015 Aug; 53(8):2502-8. PubMed ID: 26019204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Xpert(®) MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis.
    Ramirez HL; García-Clemente MM; Alvarez-Álvarez C; Palacio-Gutierrez JJ; Pando-Sandoval A; Gagatek S; Arias-Guillén M; Quezada-Loaiza CA; Casan-Clará P
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):435-7. PubMed ID: 24670698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact and cost analysis of the use of either the Xpert MTB Rif test or sputum smear microscopy in the diagnosis of pulmonary tuberculosis in Rio de Janeiro, Brazil.
    Castro AZ; Moreira AR; Oliveira J; Costa PA; Graça CLALD; Pérez MA; Kritski A; Vater MC
    Rev Soc Bras Med Trop; 2018; 51(5):631-637. PubMed ID: 30304269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
    Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
    Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil.
    Guerra RL; Dorman SE; Luiz RR; Conde MB
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1336-40. PubMed ID: 24025387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis.
    Lee HY; Seong MW; Park SS; Hwang SS; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):917-21. PubMed ID: 23621953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.
    Choi HW; Miele K; Dowdy D; Shah M
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1328-35. PubMed ID: 24025386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    Kaso AW; Hailu A
    PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area.
    You JH; Lui G; Kam KM; Lee NL
    J Infect; 2015 Apr; 70(4):409-14. PubMed ID: 25573001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert(®) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Mbonze NB; Tabala M; Wenzi LK; Bakoko B; Brouwer M; Creswell J; Van Rie A; Behets F; Yotebieng M
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):240-6. PubMed ID: 26792478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of molecular and immunological methods for the rapid diagnosis of smear-negative tuberculosis.
    Jafari C; Ernst M; Kalsdorf B; Lange C
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1459-65. PubMed ID: 24125451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria.
    Umar NA; Abubakar I; Fordham R; Bachmann M
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):835-40. PubMed ID: 22613686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of different diagnostic algorithms for pulmonary tuberculosis varying in placement of Xpert MTB/RIF.
    Chadha VK; Sebastian G; Kumar P
    Indian J Tuberc; 2016 Jan; 63(1):19-27. PubMed ID: 27235940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.